De-Risking Your Way to a Successful Fundraise: Interview with WearLinq CEO Konrad Morzkowski

In this episode of Medsider Radio, we sat down with Konrad Morzkowski, co-founder and CEO of WearLinq. The startup is commercializing eWave, an FDA-cleared EKG monitor for continuous cardiac monitoring. Konrad is an engineer from Sweden and a member of Forbes’ 30 under 30 list. After obtaining an MS at Stanford – where he met his co-founders and raised his first round – Konrad dove right into entrepreneurship with WearLinq, a company commercializing consumer-facing digital healthcare solutions with an initial focus on EKG monitoring. In this interview, Konrad shares how he optimizes fundraising efforts by aligning them with important milestones, his unconventional methods to gather voice of customer research, and how his startup moved rapidly through product design iterations. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Konrad Morzkowski.